Sulpiride is usually well-tolerated, producing few adverse effects. Their incidences are as follows:<ref name = EMC/><ref name = Maudsley/><ref>{{cite journal|title=Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial|journal=Acta Psychiatrica Scandinavica|volume=80|issue=1|date=July 1989|pages=92–96|pmid=2669445|author1=Lepola, U |author2=Koskinen, T |author3=Rimón, R |author4=Salo, H |author5=Gordin, A |doi=10.1111/j.1600-0447.1989.tb01305.x}}</ref><ref>{{cite journal|title=Sulpiride versus haloperidol, a clinical trial in schizophrenia. A preliminary report|journal=Acta Psychiatrica Scandinavica Supplementum|volume=311|pages=31–41|author1=Munk-Andersen, E |author2=Behnke, K |author3=Heltberg, J |author4=Nielsen, H |author5=Gerlach, J |pmid=6367362|year=1984}}</ref><ref>{{cite journal|journal=British Journal of Psychiatry|volume=147|pages=283–288|pmid=3904885|title=Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations|author1=Gerlach, J |author2=Behnke, K |author3=Heltberg, J |author4=Munk-Anderson, E |author5=Nielsen, H |date=Sep 1985|doi=10.1192/bjp.147.3.283}}</ref><ref>{{cite journal|title=A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder|journal=Psychopharmacology|year=1983|volume=81|issue=3|pages=258–260|pmid=6417717|author1=Standish-Barry, HM |author2=Bouras, N |author3=Bridges, PK |author4=Watson, JP |doi=10.1007/bf00427274}}</ref><ref>{{cite journal|title=A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia|journal=Journal of Neurology, Neurosurgery and Psychiatry|author1=Quinn, N |author2=Marsden, CD |volume=47|issue=8|pages=844–847|pmid=6236286|pmc=1027949|date=August 1984|doi=10.1136/jnnp.47.8.844|url=http://jnnp.bmj.com/content/47/8/844.full.pdf}}</ref><ref>{{cite journal|title=Clinical trials of benzamides in psychiatry|journal=Advances in Biochemical Psychopharmacology|author1=Peselow, ED |author2=Stanley, M |volume=35|pages=163–194|year=1982|pmid=6756060}}</ref><ref>{{cite journal|title=Controlled trial of sulpiride in chronic schizophrenic patients|journal=The British Journal of Psychiatry|date=December 1980|pages=522–529|volume=137|pmid=7011469|author1=Edwards, JG |author2=Alexander, JR |author3=Alexander, MS |author4=Gordon, A |author5=Zutchi, T |doi=10.1192/bjp.137.6.522}}</ref>

 


 
;Common (>1%) adverse effects:

 
* Dizziness

 
* Headache

 
* Extrapyramidal side effects

 
:- Tremor

 
:- Dystonia

 
:- [[Akathisia]] — a sense of inner restlessness that presents itself with the inability to stay still

 
:- [[Parkinsonism]]

 
* Somnolence (not a very prominent adverse effect considering its lack of α<sub>1</sub> adrenergic, histamine and muscarinic acetylcholine receptor affinity)

 
* Insomnia

 
* Weight gain or loss

 
* [[Hyperprolactinemia]] (elevated plasma levels of the hormone, [[prolactin]] which can, in turn lead to sexual dysfunction, [[galactorrhea]], [[amenorrhea]], [[gynecomastia]], etc.)

 
* Nausea

 
* Vomiting

 
* Nasal congestion

 
* [[Anticholinergic]] adverse effects such as:

 
:- Dry mouth

 
:- Constipation

 
:- Blurred vision

 
* Impaired concentration

 


 
;Rare (<1% incidence) adverse effects:

 
* [[Tardive dyskinesia]] — a rare, often permanent movement disorder that, more often than not, results from prolonged treatment with antidopaminergic agents such as antipsychotics. It presents with slow (hence ''tardive''), involuntary, repetitive and purposeless movements that most often affect the facial muscles. 

 
* [[Neuroleptic malignant syndrome]] — a rare, life-threatening complication that results from the use of antidopaminergic agents. Its incidence increases with concomitant use of [[lithium (medication)]] salts

 
* Blood dyscrasias — rare, sometimes life-threatening complications of the use of a number of different antipsychotics (most notably clozapine) which involves abnormalities in the composition of a person's blood (e.g. having too few white blood cells per unit volume of blood). Examples include: 

 
:- [[Agranulocytosis]] — a significant drop in white blood cell count, leaving individuals wide open to life-threatening opportunistic infections

 
:- [[Neutropenia]]

 
:- [[Leucopenia]]

 
:- [[Leukocytosis]]<ref>{{cite journal|title=Leukocytosis related to the therapeutic dosage of sulpiride|journal=Biological Psychiatry|volume=35|issue=12|pages=963|date=June 1994|authors=Levkovitz, H; Abramovitch, Y; Nitzan, I|pmid=8080896|doi=10.1016/0006-3223(94)91244-0}}</ref>

 
* Seizures

 
* [[Torsades de pointes]]

 


 
;Unknown incidence adverse effects include:

 
* [[QTc interval]] prolongation which can lead to potentially fatal [[arrhythmias]].

 
* Cholestatic jaundice<ref>{{cite journal|title=Severe cholestatic jaundice due to sulpiride|journal=Israel Journal of Medical Sciences|author1=Melzer, E |author2=Knobel, B |volume=23|issue=12|pages=1259–1260|date=December 1987|pmid=3326861}}</ref>

 
* Elevated liver enzymes

 
* Primary biliary cirrhosis<ref>{{cite journal|title=Symptomatic primary biliary cirrhosis triggered by administration of sulpiride|journal=The American Journal of Gastroenterology|doi=10.1111/j.1572-0241.1999.01634.x|pmid=10606349|author1=Ohmoto, K |author2=Yamamoto, S |author3=Hirokawa, M |volume=94|issue=12|pages=3660–3661|date=December 1999}}</ref>

 
* Allergic reactions

 
* Photosensitivity — sensitivity to light

 
* Skin rashes

 
* Depression

 
* [[Catatonia]]

 
* Palpitations

 
* Agitation

 
* [[Diaphoresis]] — sweating without a precipitating factor (e.g. increased ambient temperature)

 
* Hypotension — low blood pressure

 
* Hypertension — high blood pressure

 
* [[Venous thromboembolism]] (probably ''rare'')

 

